Among patients with end-stage renal disease (ESRD), those with concomitant psoriasis are younger and more often have cancer, diabetes mellitus, and coronary artery disease, according to a study published in the Journal of Clinical Medicine. Johannes Wild, MD, and colleagues examined the impact of concomitant psoriasis on the in-hospital outcomes of patients with ESRD. Among 360,980 hospitalizations of patients treated for ESRD during 2010- 2020, 0.3% also had psoriasis. Within the time period, the annual number of all patients with ESRD increased, but slight decreases were seen in the number of patients with ESRD and psoriasis. Patients with ESRD and psoriasis were younger (aged 66 vs 71), more often obese (17.5% vs 8.2%), and more often had cancer (4.9% vs 3.3%), diabetes mellitus (42.7% vs 38.5%), and coronary artery disease (31.1% vs 28.0%). Psoriasis was not associated with in hospital case fatality in multivariate regression models.
